Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cryoport, Inc. stock logo
CYRX
Cryoport
$16.11
+0.3%
$16.83
$9.00
$24.17
$791.97M1.6449,026 shs296,906 shs
Dicerna Pharmaceuticals, Inc. stock logo
DRNA
Dicerna Pharmaceuticals
$38.22
$38.12
$19.06
$40.14
$2.99B0.81.34 million shsN/A
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
$7.70
+14.1%
$10.82
$3.81
$17.70
$452.68M0.26278,781 shs413,493 shs
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
$23.67
-0.8%
$27.08
$14.89
$32.53
$2.14B1.07713,084 shs451,559 shs
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
$42.30
+0.1%
$42.13
$24.39
$45.76
$1.59B0.6147,109 shs22,565 shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cryoport, Inc. stock logo
CYRX
Cryoport
-0.43%-5.64%-8.75%+7.64%-28.50%
Dicerna Pharmaceuticals, Inc. stock logo
DRNA
Dicerna Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
-6.25%-28.27%-34.40%-43.56%-40.27%
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
+4.69%-0.58%-12.27%-15.38%+28.75%
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
+0.07%+0.36%+0.45%+0.52%+71.80%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cryoport, Inc. stock logo
CYRX
Cryoport
0.7346 of 5 stars
2.12.00.00.00.63.30.6
Dicerna Pharmaceuticals, Inc. stock logo
DRNA
Dicerna Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
3.9066 of 5 stars
3.30.00.04.62.34.20.6
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
4.4334 of 5 stars
4.40.00.04.71.84.20.6
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
1.129 of 5 stars
1.05.00.00.01.02.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cryoport, Inc. stock logo
CYRX
Cryoport
2.29
Hold$18.6315.61% Upside
Dicerna Pharmaceuticals, Inc. stock logo
DRNA
Dicerna Pharmaceuticals
N/AN/AN/AN/A
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
2.50
Moderate Buy$17.44126.55% Upside
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
2.89
Moderate Buy$52.13120.22% Upside
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
2.00
Hold$43.001.65% Upside

Current Analyst Ratings

Latest CYRX, DRNA, TARO, RCKT, and IGMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$12.00
4/10/2024
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$53.00
4/4/2024
Cryoport, Inc. stock logo
CYRX
Cryoport
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$17.00 ➝ $21.00
4/2/2024
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$39.00
3/15/2024
Cryoport, Inc. stock logo
CYRX
Cryoport
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$14.50 ➝ $17.00
3/13/2024
Cryoport, Inc. stock logo
CYRX
Cryoport
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingEqual Weight ➝ Equal Weight$17.00
3/13/2024
Cryoport, Inc. stock logo
CYRX
Cryoport
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy$19.00 ➝ $18.00
3/1/2024
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$56.00 ➝ $54.00
2/27/2024
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$55.00 ➝ $50.00
2/27/2024
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$65.00
2/13/2024
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$53.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cryoport, Inc. stock logo
CYRX
Cryoport
$233.26M3.40$0.39 per share41.23$9.45 per share1.70
Dicerna Pharmaceuticals, Inc. stock logo
DRNA
Dicerna Pharmaceuticals
$164.31M18.17N/AN/A$1.84 per share20.77
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
$2.13M212.53N/AN/A$3.46 per share2.23
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
N/AN/AN/AN/A$5.46 per shareN/A
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
$572.95M2.78$1.75 per share24.15$46.05 per share0.92

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cryoport, Inc. stock logo
CYRX
Cryoport
-$99.59M-$2.20N/AN/AN/A-42.69%-11.86%-5.99%5/2/2024 (Estimated)
Dicerna Pharmaceuticals, Inc. stock logo
DRNA
Dicerna Pharmaceuticals
-$112.75M-$1.63N/AN/AN/A-64.53%-103.08%-16.58%N/A
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
-$246.42M-$4.81N/AN/AN/A-11,568.83%-103.20%-53.53%5/10/2024 (Estimated)
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
-$245.60M-$2.94N/AN/AN/AN/A-51.83%-45.87%5/2/2024 (Estimated)
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
$25.44M$1.2234.67N/A7.48%3.26%2.67%5/28/2024 (Estimated)

Latest CYRX, DRNA, TARO, RCKT, and IGMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/12/2024Q4 2023
Cryoport, Inc. stock logo
CYRX
Cryoport
-$0.32-$0.51-$0.19$0.29$58.27 million$57.26 million
3/7/2024Q4 2023
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
-$1.06-$1.01+$0.05-$1.01$0.95 million$0.65 million
2/26/202412/31/2023
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
-$0.78-$0.64+$0.14-$0.64N/AN/A
1/25/2024Q3 2024
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
$0.30$0.56+$0.26$0.58$154.90 million$157.15 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cryoport, Inc. stock logo
CYRX
Cryoport
N/AN/AN/AN/AN/A
Dicerna Pharmaceuticals, Inc. stock logo
DRNA
Dicerna Pharmaceuticals
N/AN/AN/AN/AN/A
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
N/AN/AN/AN/AN/A
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
N/AN/AN/AN/AN/A
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cryoport, Inc. stock logo
CYRX
Cryoport
0.82
11.73
11.16
Dicerna Pharmaceuticals, Inc. stock logo
DRNA
Dicerna Pharmaceuticals
N/A
2.46
2.46
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
N/A
8.18
8.18
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
0.04
7.80
7.80
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
N/A
3.60
3.03

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cryoport, Inc. stock logo
CYRX
Cryoport
1,17049.16 million44.20 millionOptionable
Dicerna Pharmaceuticals, Inc. stock logo
DRNA
Dicerna Pharmaceuticals
30278.13 million70.16 millionOptionable
IGM Biosciences, Inc. stock logo
IGMS
IGM Biosciences
22458.79 million25.33 millionOptionable
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
26890.50 million62.36 millionOptionable
Taro Pharmaceutical Industries Ltd. stock logo
TARO
Taro Pharmaceutical Industries
1,55437.59 million32.40 millionOptionable

CYRX, DRNA, TARO, RCKT, and IGMS Headlines

SourceHeadline
Taro Pharmaceutical Board Relies on Flawed Analysis to Shortchange Minority ShareholdersTaro Pharmaceutical Board Relies on Flawed Analysis to Shortchange Minority Shareholders
finance.yahoo.com - April 23 at 7:41 AM
Yoho takes Ohio Pharmacists Association postYoho takes Ohio Pharmacists Association post
newsandsentinel.com - April 21 at 9:58 AM
Taro to hold meetings for approval of merger with Sun Pharmaceutical IndustriesTaro to hold meetings for approval of merger with Sun Pharmaceutical Industries
drugstorenews.com - April 19 at 2:51 PM
StockNews.com Begins Coverage on Taro Pharmaceutical Industries (NYSE:TARO)StockNews.com Begins Coverage on Taro Pharmaceutical Industries (NYSE:TARO)
americanbankingnews.com - April 19 at 2:14 AM
Middle East crisis escalation may hurt pharma exportsMiddle East crisis escalation may hurt pharma exports
msn.com - April 18 at 7:17 PM
Taro Pharmaceutical Industries Ltd TALTaro Pharmaceutical Industries Ltd TAL
morningstar.com - April 17 at 12:41 AM
JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?JNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?
stocknews.com - April 15 at 5:00 PM
Israel-Iran stand-off has drugmakers on the edgeIsrael-Iran stand-off has drugmakers on the edge
thehindubusinessline.com - April 15 at 3:53 PM
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
businesswire.com - April 15 at 8:00 AM
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Short Interest UpdateTaro Pharmaceutical Industries Ltd. (NYSE:TARO) Short Interest Update
marketbeat.com - April 12 at 9:38 PM
Taro Pharmaceutical Industries (NYSE:TARO) Stock Crosses Above 200 Day Moving Average of $39.61Taro Pharmaceutical Industries (NYSE:TARO) Stock Crosses Above 200 Day Moving Average of $39.61
marketbeat.com - April 11 at 3:14 AM
Taro Pharmaceutical Industries (NYSE:TARO) Research Coverage Started at StockNews.comTaro Pharmaceutical Industries (NYSE:TARO) Research Coverage Started at StockNews.com
marketbeat.com - April 11 at 2:15 AM
Sensexs Top Laggards Could Be In For A TurnaroundSensex's Top Laggards Could Be In For A Turnaround
ndtvprofit.com - April 9 at 6:38 PM
Global Takotsubo Syndrome Therapeutics Market Set to Witness Significant Growth, Reaching US$ 2.85 Billion by 2033Global Takotsubo Syndrome Therapeutics Market Set to Witness Significant Growth, Reaching US$ 2.85 Billion by 2033
fmiblog.com - April 5 at 2:56 AM
Sun Pharmaceutical Industries gets grant for dermal patch system for collecting physiological samplesSun Pharmaceutical Industries gets grant for dermal patch system for collecting physiological samples
pharmaceutical-technology.com - March 29 at 7:34 PM
Taro Pharmaceuticals U.S.A., Inc. Expands OTC Portfolio for Children with the Introduction of bébé Bottoms™ Diaper Rash Crème SprayTaro Pharmaceuticals U.S.A., Inc. Expands OTC Portfolio for Children with the Introduction of bébé Bottoms™ Diaper Rash Crème Spray
finance.yahoo.com - March 28 at 6:32 PM
CHPA, Health In Hand Foundation elect new board members at annual summitCHPA, Health In Hand Foundation elect new board members at annual summit
drugstorenews.com - March 28 at 1:31 PM
Taro Pharmaceutical Industries Ltd. (TARO)Taro Pharmaceutical Industries Ltd. (TARO)
finance.yahoo.com - March 27 at 10:29 PM
Taro Pharmaceutical Industries LtdTaro Pharmaceutical Industries Ltd
morningstar.com - March 22 at 6:26 PM
Rapid Expansion Projected for Global Genital Warts Treatment Market by 2033 | Market.usRapid Expansion Projected for Global Genital Warts Treatment Market by 2033 | Market.us
pharmiweb.com - March 18 at 4:22 PM
Sun Pharmas growth pill: Specialising in specialty and scaling in IndiaSun Pharma's growth pill: Specialising in specialty and scaling in India
business-standard.com - March 17 at 6:54 PM
Crescita Therapeutics Inc. Reports Q4 and Fiscal 2023 ResultsCrescita Therapeutics Inc. Reports Q4 and Fiscal 2023 Results
finanznachrichten.de - March 13 at 8:15 AM
Sun Pharma initiates recall of Febuxostat for gout in USSun Pharma initiates recall of Febuxostat for gout in US
msn.com - March 11 at 6:00 PM
Sun Pharma issues recall of gout drug due to microbial contaminationSun Pharma issues recall of gout drug due to microbial contamination
fiercepharma.com - March 11 at 12:59 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cryoport logo

Cryoport

NASDAQ:CYRX
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
Dicerna Pharmaceuticals logo

Dicerna Pharmaceuticals

NASDAQ:DRNA
Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA.
IGM Biosciences logo

IGM Biosciences

NASDAQ:IGMS
IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmune and inflammatory diseases. It develops Aplitabart, a Death Receptor 5 Agonist IgM antibody for the treatment of colorectal cancer; imvotamab, a CD20 x CD3 bispecific IgM antibody to treat myositis, as well as for the treatment of systemic lupus erythematosus and rheumatoid arthritis that is Phase Ib clinical trial; and IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of autoimmune diseases. IGM Biosciences, Inc. has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
Rocket Pharmaceuticals logo

Rocket Pharmaceuticals

NASDAQ:RCKT
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure; Plakophilin-2 Arrhythmogenic Cardiomyopathy, an inheritable cardiac disorder; and BAG3 Dilated Cardiomyopathy. It has license agreements with Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Cranbury, New Jersey.
Taro Pharmaceutical Industries logo

Taro Pharmaceutical Industries

NYSE:TARO
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.